focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Goldman upgrades Aston Martin to 'buy', shares rally

Wed, 19th Jul 2023 10:23

(Sharecast News) - Goldman Sachs upgraded its stance on Aston Martin Lagonda on Wednesday to 'buy' from 'neutral' as it argued that new products pave the way for a turnaround in fortunes.

The bank said it was upgrading the shares "ahead of a 24-month period during which we expect steady progress".

Through to the end of 2024, Goldman expects Aston Martin to unveil one new core model every quarter, creating an unprecedented pipeline.

"Over the same period, new specials should help to bolster higher average selling prices, gross margins and ultimately EBITDA," it said.

GS expects the luxury car maker to deliver 2H23 adjusted EBITDA of €244mn, a run-rate close to AML's €500mn 2024/25 target.

"As AML introduces its next-generation products, we forecast a step forward in ASPs and gross margins," GS said.

"We believe solid initial sales of core models and the contribution from specials provide a degree of certainty over AML's 2024 financials, and 'an option' on medium-term success.

"However, for greater conviction that AML can achieve ASPs and margins consummate with the luxury peer group on a sustained basis, we believe it is necessary to assess waitlists, ASPs and volumes more than 12 months after new products launch."

Goldman noted that despite the year-to-date performance, AML shares are down 37% since the start of 2022.

"We do not believe the share price gives full credit to AML meeting its near-term (2024/25) targets," it said. "On average, we see AML reaching these targets with £2.1bn in revenue and £515mn of adjusted EBITDA."

At 1020 BST, the shares were up 5.5% at 349p.

Related Shares

More News
3 May 2024 16:52

London close: Stocks rise as US payrolls come in weaker

(Sharecast News) - London markets closed positively on Friday, as investors digested slower-than-expected payrolls growth in the US, while Anglo Ameri...

2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2% *

1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...

1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending polic...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.